All stock lists
Stellus Capital Investment Corp (New York Stock Exchange:SCM)
US · Delayed Price · Currency is USD
Financial Services · Asset Management
$6.21-$0.07 (-1.11%)
Market cap
$175M
Insider Score
Health Score
Analyst consensus
Listed since
Nov 8, 2012
Website
Insider Score
79/ 100
SCM Insider Score
Bullish1 qualifying trade · 1 insider · $197.10K bought in the last 90 days
Financial Health Score
Sound
From SCM’s reported statements · Q3 2026 (trailing 12 months)
Profitability20 / 20
Keeps a healthy share of every dollar it sells.
- Revenue
- $84.5M
- Net income
- $16.7M
- Net margin
- 19.8%
Leverage0 / 20
Heavily indebted for what it earns.
- Total debt
- $608.4M
- Cash
- $2.3M
- Net debt / EBITDA
- 17.16x
Liquidity0 / 20
Owes more within a year than it holds to pay it.
- Current assets
- $7.7M
- Current liabilities
- $16.2M
- Current ratio
- 0.48
Cash generation20 / 20
The business funds itself from operations.
- Operating cash flow
- $66.2M
- Free cash flow
- $66.2M
- FCF margin
- 78.3%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 28.5M
- Share growth (1y)
- -0.1%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
SCM Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | $22.40 M | $22.30 M | $24.04 M | $15.72 M | $17.43 M | $19.84 M |
| Revenue Growth (YoY) | 28.51 % | 12.40 % | 72.17 % | -13.65 % | -30.76 % | 19.53 % |
| Cost of Revenue | $5.76 M | $8.59 M | $5.30 M | $9.05 M | $8.95 M | $8.68 M |
| Gross Profit | $16.64 M | $13.72 M | $18.74 M | $6.67 M | $8.48 M | $11.16 M |
| SG&A Expense | $631.31 B | $6.16 M | $1057.34 B | $1.92 M | $1.58 M | $1.52 M |
| R&D Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $14.34 M | -$2.52 M | $7.83 M | $1.32 M | $1.27 M | $588.89 K |
| Operating Income | $2.31 M | $16.24 M | $10.91 M | $5.35 M | $7.21 M | $10.57 M |
| Pretax Income | -$6.07 M | $16.24 M | $2.02 M | $5.35 M | $7.21 M | $10.57 M |
| Tax Provision | $307.10 K | $29.68 K | $360.47 K | $136.15 K | $515.69 K | $428.95 K |
| Net Income | -$6.37 M | $16.21 M | $1.66 M | $5.21 M | $6.69 M | $10.15 M |
| EPS (Basic) | -$0.22 | $0.56 | $0.06 | $0.18 | $0.23 | $0.36 |
| EPS (Diluted) | -$0.22 | $0.56 | $0.06 | $0.18 | $0.23 | $0.36 |
| Shares Outstanding | 28.47 M | 28.87 M | 28.95 M | 28.36 M | 28.48 M | 28.41 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
